new on the range
Bimeda is pleased to announce the launch
of Macrosyn (tulathromycin injection) 100mg.
Macrosyn is a ready-to-use injectable solution
containing 100 mg of tulathromycin/mL, a broad
spectrum, fast-acting antibiotic for use in cattle
Macrosyn is available in 100mL, 250mL, and
500mL sizes. In gaining approval from the U.S. Food and
Drug Administration (FDA), Macrosyn was granted the
same label claims as Draxxin and is bioequivalent to the
pioneer product in:
• Active ingredient & inactive ingredients (including
carriers and excipients)
• Strength, dosage form & route of administration
Additionally, Macrosyn meets the same quality and
safety requirements and is manufactured at an approved
Macrosyn, the first brand alternative tulathromycin
available for the top-selling injectable antibiotic product
in the US, is indicated for use to treat specific conditions
caused by specific bacteria susceptible to tulathromycin:
• In beef and non-lactating dairy cattle, Macrosyn
is approved for the control & treatment of bovine
respiratory disease (BRD) (Mannheimia haemolytica,
Pasteurella multocida, Histophilus somni,
Mycoplasma bovis), treatment of bovine foot rot
(Fusobacterium necrophorum, Porphyromonas levii),
and treatment of pink eye (Moraxella bovis).
• In calves (suckling, dairy and veal calves) Macrosyn
is approved for the treatment of bovine respiratory
disease (BRD) (M. haemolytica, P. multocida, H.
somni, M. bovis).
For more information visit www.bimedaus.com or call
Bimeda at (888) 524-6332.
APRIL / MAY 2021 I WORKING RANCH I 21